PDF factsheet
      Z

cholesterol lowering intervention in hypertension for all type of patients, clinical trials results

atorvastatin versus placebo
ASCOT, 2003
atorvastatin 10mg/d
versus
placebo
hypertensive patients aged 40-79 years with at least three other cardiovascular risk factorsdouble blind
Follow-up duration: 3.3 years
UK et Scandinavie
fluvastatin versus placebo
HYRIM, 2005
fluvastatin 40 mg daily
versus
placebo
drug-treated hypertensive men aged 40-74 years with total cholesterol 4.5-8.0 mmol/L, triglycerides <4.5 mmol/L, body mass index 25-35 kg/m2, and a sedentary lifestyledouble blind
Follow-up duration: 4 year
Norway

  Options


in first

in second

  Filter